Related references
Note: Only part of the references are listed.Arterial Delivery of VEGF-C Stabilizes Atherosclerotic Lesions
Carlos Silvestre-Roig et al.
CIRCULATION RESEARCH (2021)
Associations of Adiposity, Circulating Protein Biomarkers, and Risk of Major Vascular Diseases
Yuanjie Pang et al.
JAMA CARDIOLOGY (2021)
Biased agonism at chemokine receptors
Dylan Scott Eiger et al.
CELLULAR SIGNALLING (2021)
Carotid Plaque Inflammation Imaged by PET and Prediction of Recurrent Stroke at 5 Years
John Joseph McCabe et al.
NEUROLOGY (2021)
Monocyte-Chemoattractant Protein-1 Levels in Human Atherosclerotic Lesions Associate With Plaque Vulnerability
Marios K. Georgakis et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2021)
Efficacy and safety of low-dose colchicine in patients with coronary disease: a systematic review and meta-analysis of randomized trials
Aernoud T. L. Fiolet et al.
EUROPEAN HEART JOURNAL (2021)
Association of Circulating Monocyte Chemoattractant Protein-1 Levels With Cardiovascular Mortality A Meta-analysis of Population-Based Studies
Marios K. Georgakis et al.
JAMA CARDIOLOGY (2021)
Biased action of the CXCR4-targeting drug plerixafor is essential for its superior hematopoietic stem cell mobilization
Astrid S. Jorgensen et al.
COMMUNICATIONS BIOLOGY (2021)
Rare variant contribution to human disease in 281,104 UK Biobank exomes
Quanli Wang et al.
NATURE (2021)
Nanotherapeutics for cardiovascular disease
Bryan Ronain Smith
NATURE REVIEWS CARDIOLOGY (2021)
Noninvasive Imaging to Assess Atherosclerotic Plaque Composition and Disease Activity Coronary and Carotid Applications
Marwa Daghem et al.
JACC-CARDIOVASCULAR IMAGING (2020)
Atherosclerosis Immunoimaging by Positron Emission Tomography
Carlos Perez-Medina et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2020)
Low-density lipoproteins cause atherosclerotic cardiovascular disease: pathophysiological, genetic, and therapeutic insights: a consensus statement from the European Atherosclerosis Society Consensus Panel
Jan Boren et al.
EUROPEAN HEART JOURNAL (2020)
CCR2 Positron Emission Tomography for the Assessment of Abdominal Aortic Aneurysm Inflammation and Rupture Prediction
Sean J. English et al.
CIRCULATION-CARDIOVASCULAR IMAGING (2020)
Carotid Intima-Media Thickness Progression as Surrogate Marker for Cardiovascular Risk Meta-Analysis of 119 Clinical Trials Involving 100 667 Patients
Peter Willeit et al.
CIRCULATION (2020)
Novel Positron Emission Tomography Tracers for Imaging Vascular Inflammation
Andrej Corovic et al.
CURRENT CARDIOLOGY REPORTS (2020)
Colchicine Attenuates Inflammation Beyond the Inflammasome in Chronic Coronary Artery Disease A LoDoCo2 Proteomic Substudy
Tjerk S. J. Opstal et al.
CIRCULATION (2020)
Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019
Theo Vos et al.
LANCET (2020)
Colchicine in Patients with Chronic Coronary Disease
Stefan M. Nidorf et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Nanoparticle-encapsulated siRNAs for gene silencing in the haematopoietic stem-cell niche
Marvin Krohn-Grimberghe et al.
NATURE BIOMEDICAL ENGINEERING (2020)
Designed CXCR4 mimic acts as a soluble chemokine receptor that blocks atherogenic inflammation by agonist-specific targeting
Christos Kontos et al.
NATURE COMMUNICATIONS (2020)
Anticytokine Agents Targeting Interleukin Signaling Pathways for the Treatment of Atherothrombosis
Paul M. Ridker
CIRCULATION RESEARCH (2019)
Macrophage Migration Inhibitory Factor (MIF)-Based Therapeutic Concepts in Atherosclerosis and Inflammation
Dzmitry Sinitski et al.
THROMBOSIS AND HAEMOSTASIS (2019)
Chemokines as Therapeutic Targets in Cardiovascular Disease The Road Behind, The Road Ahead
Heidi Noels et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2019)
Immunotherapy for cardiovascular disease
Esther Lutgens et al.
EUROPEAN HEART JOURNAL (2019)
Residual Inflammatory Risk in Patients With Low LDL Cholesterol Levels Undergoing Percutaneous Coronary Intervention
Paul Guedeney et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2019)
Vascular Inflammation in Subclinical Atherosclerosis Detected by Hybrid PET/MRI
Leticia Fernandez-Friera et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2019)
Structural basis for ligand modulation of the CCR2 conformational landscape
Bryn C. Taylor et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
FDA Approval Summary: Mogamulizumab-kpkc for Mycosis Fungoides and Sezary Syndrome
Yvette L. Kasamon et al.
CLINICAL CANCER RESEARCH (2019)
Carotid Plaque Inflammation Imaged by 18F-Fluorodeoxyglucose Positron Emission Tomography and Risk of Early Recurrent Stroke
Peter J. Kelly et al.
STROKE (2019)
Circulating Monocyte Chemoattractant Protein-1 and Risk of Stroke Meta-Analysis of Population-Based Studies Involving 17 180 Individuals
Marios K. Georgakis et al.
CIRCULATION RESEARCH (2019)
Carotid Plaque Positron Emission Tomography Imaging and Cerebral Ischemic Disease: A Systematic Review and Meta-Analysis
Salama Chaker et al.
STROKE (2019)
Efficacy and Safety of Low-Dose Colchicine after Myocardial Infarction
Jean-Claude Tardif et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Genetically Determined Levels of Circulating Cytokines and Risk of Stroke: Role of Monocyte Chemoattractant Protein-1
Marios K. Georgakis et al.
CIRCULATION (2019)
Tissue Resident CCR2-and CCR2+Cardiac Macrophages Differentially Orchestrate Monocyte Recruitment and Fate Specification Following Myocardial Injury
Geetika Bajpai et al.
CIRCULATION RESEARCH (2019)
Evaluation and extension of the two-site, two-step model for binding and activation of the chemokine receptor CCR1
Julie Sanchez et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2019)
Low-Dose Methotrexate for the Prevention of Atherosclerotic Events
Paul M. Ridker et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Targeting Residual Inflammatory Risk: A Shifting Paradigm for Atherosclerotic Disease
Aaron W. Aday et al.
FRONTIERS IN CARDIOVASCULAR MEDICINE (2019)
The Multitasking Potential of Alarmins and Atypical Chemokines
Aphrodite Kapurniotu et al.
FRONTIERS IN MEDICINE (2019)
Chrono-pharmacological Targeting of the CCL2-CCR2 Axis Ameliorates Atherosclerosis
Carla Winter et al.
CELL METABOLISM (2018)
Modulation of the interleukin-6 signalling pathway and incidence rates of atherosclerotic events and all-cause mortality: analyses from the Canakinumab Anti-Inflammatory Thrombosis Outcomes Study (CANTOS)
Paul M. Ridker et al.
EUROPEAN HEART JOURNAL (2018)
A guide to chemokines and their receptors
Catherine E. Hughes et al.
FEBS JOURNAL (2018)
Improved Cognitive Performance and Reduced Monocyte Activation in Virally Suppressed Chronic HIV After Dual CCR2 and CCR5 Antagonism
Michelle L. D'Antoni et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2018)
Relationship of C-reactive protein reduction to cardiovascular event reduction following treatment with canakinumab: a secondary analysis from the CANTOS randomised controlled trial
Paul M. Ridker et al.
LANCET (2018)
G Protein-Coupled Receptors as Targets for Approved Drugs: How Many Targets and How Many Drugs?
Krishna Sriram et al.
MOLECULAR PHARMACOLOGY (2018)
Repeating experiments is not enough
Marcus R. Munafo et al.
NATURE (2018)
The human heart contains distinct macrophage subsets with divergent origins and functions
Geetika Bajpai et al.
NATURE MEDICINE (2018)
Intracellular Receptor Modulation: Novel Approach to Target GPCRs
Natalia V. Ortiz Zacarias et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2018)
Viral GPCR US28 can signal in response to chemokine agonists of nearly unlimited structural degeneracy
Timothy F. Miles et al.
ELIFE (2018)
Pyrrolone Derivatives as Intracellular Allosteric Modulators for Chemokine Receptors: Selective and Dual-Targeting Inhibitors of CC Chemokine Receptors 1 and 2
Natalia V. Ortiz Zacarias et al.
JOURNAL OF MEDICINAL CHEMISTRY (2018)
Mogamulizumab versus vorinostat in previously treated cutaneous T-cell lymphoma (MAVORIC): an international, open-label, randomised, controlled phase 3 trial
Youn H. Kim et al.
LANCET ONCOLOGY (2018)
Macrophage Biology, Classification, and Phenotype in Cardiovascular Disease JACC Macrophage in CVD Series (Part 1)
Jesse W. Williams et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2018)
Biased antagonism of CXCR4 avoids antagonist tolerance
Ben Hitchinson et al.
SCIENCE SIGNALING (2018)
Partial Agonist and Biased Signaling Properties of the Synthetic Enantiomers J113863/UCB35625 at Chemokine Receptors CCR2 and CCR5
Jenny Corbisier et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2017)
Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel
Brian A. Ference et al.
EUROPEAN HEART JOURNAL (2017)
Structure of CC Chemokine Receptor 5 with a Potent Chemokine Antagonist RevealsMechanisms of Chemokine Recognition and Molecular Mimicry by HIV
Yi Zheng et al.
IMMUNITY (2017)
Inflammatory Ly6Chi monocytes and their conversion to M2 macrophages drive atherosclerosis regression
Karishma Rahman et al.
JOURNAL OF CLINICAL INVESTIGATION (2017)
CCR2 Regulates the Immune Response by Modulating the Interconversion and Function of Effector and Regulatory T Cells
Eszter Bakos et al.
JOURNAL OF IMMUNOLOGY (2017)
Serum concentrations of MCP-1 and IL-6 in combination predict the presence of coronary artery disease and mortality in subjects undergoing coronary angiography
Mohammad Tajfard et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2017)
Mendelian randomization in cardiometabolic disease: challenges in evaluating causality
Michael V. Holmes et al.
NATURE REVIEWS CARDIOLOGY (2017)
Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease
P. M. Ridker et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
CYCLOPS reveals human transcriptional rhythms in health and disease
Ron C. Anafi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
Key determinants of selective binding and activation by the monocyte chemoattractant proteins at the chemokine receptor CCR2
Zil E. Huma et al.
SCIENCE SIGNALING (2017)
Chemokine interactome mapping enables tailored intervention in acute and chronic inflammation
Philipp von Hundelshausen et al.
SCIENCE TRANSLATIONAL MEDICINE (2017)
Key determinants of selective binding and activation by the monocyte chemoattractant proteins at the chemokine receptor CCR2
Zil E. Huma et al.
SCIENCE SIGNALING (2017)
A novel CCR2 antagonist inhibits atherogenesis in apoE deficient mice by achieving high receptor occupancy
Ilze Bot et al.
SCIENTIFIC REPORTS (2017)
CCL2 recruits T cells into the brain in a CCR2-independent manner
Oriane Cedile et al.
APMIS (2017)
Evaluation of ultrasmall superparamagnetic iron-oxide (USPIO) enhanced MRI with ferumoxytol to quantify arterial wall inflammation
Loek P. Smits et al.
ATHEROSCLEROSIS (2017)
Ly6Chigh Monocytes Oscillate in the Heart During Homeostasis and After Myocardial Infarction-Brief Report
Maximilian J. Schloss et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2017)
Monocyte subtypes and the CCR2 chemokine receptor in cardiovascular disease
Carolina N. Franca et al.
CLINICAL SCIENCE (2017)
Targeted Interleukin-10 Nanotherapeutics Developed with.a Microfluidic Chip Enhance Resolution of Inflammation in Advanced Atherosclerosis
Nazila Kamaly et al.
ACS NANO (2016)
New paradigms in chemokine receptor signal transduction: Moving beyond the two-site model
Andrew B. Kleist et al.
BIOCHEMICAL PHARMACOLOGY (2016)
The Biological Basis for Cardiac Repair After Myocardial Infarction From Inflammation to Fibrosis
Sumanth D. Prabhu et al.
CIRCULATION RESEARCH (2016)
From C-Reactive Protein to Interleukin-6 to Interleukin-1 Moving Upstream To Identify Novel Targets for Atheroprotection
Paul M. Ridker
CIRCULATION RESEARCH (2016)
Overview and potential unifying themes of the atypical chemokine receptor family
Alessandro Vacchini et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2016)
Structure of CC chemokine receptor 2 with orthosteric and allosteric antagonists
Yi Zheng et al.
NATURE (2016)
Inflammatory risk factors, biomarkers and associated therapy in ischaemic stroke
Charles C. Esenwa et al.
NATURE REVIEWS NEUROLOGY (2016)
Blockade of MCP-1/CCR4 signaling-induced recruitment of activated regulatory cells evokes an antitumor immune response in head and neck squamous cell carcinoma
Wei Sun et al.
ONCOTARGET (2016)
A double-blind randomised study to evaluate the efficacy and safety of bindarit in preventing coronary stent restenosis
Antonio Colombo et al.
EUROINTERVENTION (2016)
Chemokines Control Mobilization, Recruitment, and Fate of Monocytes in Atherosclerosis
Maik Drechsler et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2015)
Prednisolone-containing liposomes accumulate in human atherosclerotic macrophages upon intravenous administration
Fleur M. van der Valk et al.
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2015)
Structural basis for chemokine recognition and activation of a viral G protein-coupled receptor
John S. Burg et al.
SCIENCE (2015)
Crystal structure of the chemokine receptor CXCR4 in complex with a viral chemokine
Ling Qin et al.
SCIENCE (2015)
Colchicine-Update on mechanisms of action and therapeutic uses
Ying Ying Leung et al.
SEMINARS IN ARTHRITIS AND RHEUMATISM (2015)
The Chemokine System in Innate Immunity
Caroline L. Sokol et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2015)
Serum Levels of Monocyte Chemoattractant Protein-1 and All-Cause and Cardiovascular Mortality among Patients with Coronary Artery Disease
Ding Ding et al.
PLOS ONE (2015)
Usefulness of a Combination of Monocyte Chemoattractant Protein-1, Galectin-3, and N-Terminal Probrain Natriuretic Peptide to Predict Cardiovascular Events in Patients With Coronary Artery Disease
Jose Tunon et al.
AMERICAN JOURNAL OF CARDIOLOGY (2014)
Chemokines and Chemokine Receptors: Positioning Cells for Host Defense and Immunity
Jason W. Griffith et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 32 (2014)
Mechanisms of Plaque Formation and Rupture
Jacob Fog Bentzon et al.
CIRCULATION RESEARCH (2014)
Inflammatory cytokines and risk of coronary heart disease: new prospective study and updated meta-analysis
Stephen Kaptoge et al.
EUROPEAN HEART JOURNAL (2014)
Mendelian randomization: genetic anchors for causal inference in epidemiological studies
George Davey Smith et al.
HUMAN MOLECULAR GENETICS (2014)
New nomenclature for atypical chemokine receptors
Francoise Bachelerie et al.
NATURE IMMUNOLOGY (2014)
Biased and G protien-indepedent signalling of chemokine receptors
Anne Steen et al.
FRONTIERS IN IMMUNOLOGY (2014)
International Union of Pharmacology. LXXXIX. Update on the Extended Family of Chemokine Receptors and Introducing a New Nomenclature for Atypical Chemokine Receptors
Francoise Bachelerie et al.
PHARMACOLOGICAL REVIEWS (2014)
Distinct functions of chemokine receptor axes in the atherogenic mobilization and recruitment of classical monocytes
Oliver Soehnlein et al.
EMBO MOLECULAR MEDICINE (2013)
High-sensitivity C-reactive protein and atherosclerotic disease: From improved risk prediction to risk-guided therapy
Wolfgang Koenig
INTERNATIONAL JOURNAL OF CARDIOLOGY (2013)
Structure of the CCR5 Chemokine Receptor-HIV Entry Inhibitor Maraviroc Complex
Qiuxiang Tan et al.
SCIENCE (2013)
Immune regulation by atypical chemokine receptors
Robert J. B. Nibbs et al.
NATURE REVIEWS IMMUNOLOGY (2013)
Animal Models of Atherosclerosis
Godfrey S. Getz et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2012)
A Novel C-C Chemokine Receptor 2 Antagonist Prevents Progression of Albuminuria and Atherosclerosis in Mouse Models
Masayuki Okamoto et al.
BIOLOGICAL & PHARMACEUTICAL BULLETIN (2012)
Bindarit An anti-inflammatory small molecule that modulates the NF kappa B pathway
Eugenio Mora et al.
CELL CYCLE (2012)
Effects of Interleukin-1β Inhibition With Canakinumab on Hemoglobin A1c, Lipids, C-Reactive Protein, Interleukin-6, and Fibrinogen A Phase IIb Randomized, Placebo-Controlled Trial
Paul M. Ridker et al.
CIRCULATION (2012)
Effect of CC Chemokine Receptor 2 CCR2 Blockade on Serum C-Reactive Protein in Individuals at Atherosclerotic Risk and With a Single Nucleotide Polymorphism of the Monocyte Chemoattractant Protein-1 Promoter Region
Jim Gilbert et al.
AMERICAN JOURNAL OF CARDIOLOGY (2011)
The isoenzyme of glutaminyl cyclase is an important regulator of monocyte infiltration under inflammatory conditions
Holger Cynis et al.
EMBO MOLECULAR MEDICINE (2011)
Bone Marrow Mesenchymal Stem and Progenitor Cells Induce Monocyte Emigration in Response to Circulating Toll-like Receptor Ligands
Chao Shi et al.
IMMUNITY (2011)
Different Effects of the Different Natural CC Chemokine Receptor 2b Ligands on β-Arrestin Recruitment, Gαi Signaling, and Receptor Internalization
Yamina A. Berchiche et al.
MOLECULAR PHARMACOLOGY (2011)
Therapeutic siRNA silencing in inflammatory monocytes in mice
Florian Leuschner et al.
NATURE BIOTECHNOLOGY (2011)
Atherosclerosis: current pathogenesis and therapeutic options
Christian Weber et al.
NATURE MEDICINE (2011)
Overcoming hurdles in developing successful drugs targeting chemokine receptors
Thomas J. Schall et al.
NATURE REVIEWS IMMUNOLOGY (2011)
Monocyte Chemoattractant Protein-1 Deficiency Protects Against Visceral Fat-Induced Atherosclerosis
Miina K. Oehman et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2010)
Concept of Vulnerable/Unstable Plaque
Aloke V. Finn et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2010)
Nomenclature of monocytes and dendritic cells in blood
Loems Ziegler-Heitbrock et al.
BLOOD (2010)
Anti-chemokine small molecule drugs: a promising future?
Amanda E. I. Proudfoot et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2010)
FDA Review Summary: Mozobil in Combination with Granulocyte Colony-Stimulating Factor to Mobilize Hematopoietic Stem Cells to the Peripheral Blood for Collection and Subsequent Autologous Transplantation
Michael Brave et al.
ONCOLOGY (2010)
Structures of the CXCR4 Chemokine GPCR with Small-Molecule and Cyclic Peptide Antagonists
Beili Wu et al.
SCIENCE (2010)
Regulation of the Migration and Survival of Monocyte Subsets by Chemokine Receptors and Its Relevance to Atherosclerosis
Emmanuel L. Gautier et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2009)
Phase III Prospective Randomized Double-Blind Placebo-Controlled Trial of Plerixafor Plus Granulocyte Colony-Stimulating Factor Compared With Placebo Plus Granulocyte Colony-Stimulating Factor for Autologous Stem-Cell Mobilization and Transplantation for Patients With Non-Hodgkin's Lymphoma
John F. DiPersio et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Monocyte Chemoattractant Protein-1 (MCP-1): An Overview
Satish L. Deshmane et al.
JOURNAL OF INTERFERON AND CYTOKINE RESEARCH (2009)
Inflammation in Atherosclerosis From Pathophysiology to Practice
Peter Libby et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2009)
Modulation of CCR2 in rheumatoid arthritis - A double-blind, randomized, placebo-controlled clinical trial
Clarissa E. Vergunst et al.
ARTHRITIS AND RHEUMATISM (2008)
Combined inhibition of CCL2, CX3CR1, and CCR5 abrogates Ly6Chi and Ly6Clo monocytosis and almost abolishes atherosclerosis in hypercholesterolemic mice
Christophe Combadiere et al.
CIRCULATION (2008)
Fractalkine deficiency markedly reduces macrophage accumulation and atherosclerotic lesion formation in CCR2(-/-) mice - Evidence for independent chemokine functions in atherogenesis
Noah Saederup et al.
CIRCULATION (2008)
Maraviroc for previously treated patients with R5 HIV-1 infection
Roy M. Gulick et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Serial measurement of monocyte chemoattractant protein-1 after acute coronary syndromes
James A. de Lemos et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2007)
Circulating chemokines accurately identify individuals with clinically significant atherosclerotic heart disease
Diego Ardigo et al.
PHYSIOLOGICAL GENOMICS (2007)
Critical roles for CCR2 and MCP-3 in monocyte mobilization from bone marrow and recruitment to inflammatory sites
Chia-Lin Tsou et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
Identifying inflamed carotid plaques using in vivo USPIO-enhanced MR imaging to label plaque macrophages
Rikin A. Trivedi et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2006)
Monocyte emigration from bone marrow during bacterial infection requires signals mediated by chemokine receptor CCR2
NV Serbina et al.
NATURE IMMUNOLOGY (2006)
CC chemokine receptor-2 deficiency attenuates oxidative stress and infarct size caused by myocardial ischemia-reperfusion in mice
T Hayasaki et al.
CIRCULATION JOURNAL (2006)
Mechanisms of disease - The many roles of chemokines and chemokine receptors in inflammation
IF Charo et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Gene profiling in atherosclerosis reveals a key role for small inducible cytokines - Validation using a novel monocyte chemoattractant protein monoclonal antibody
E Lutgens et al.
CIRCULATION (2005)
CCL2/monocyte chemoattractant protein-1 regulates inflammatory responses critical to healing myocardial infarcts
O Dewald et al.
CIRCULATION RESEARCH (2005)
C-reactive protein levels and outcomes after statin therapy
PM Ridker et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Targeted deletion of CC chemokine receptor 2 attenuates left ventricular remodeling after experimental myocardial infarction
K Kaikita et al.
AMERICAN JOURNAL OF PATHOLOGY (2004)
Crucial role of the CCL2/CCR2 axis in neointimal hyperplasia after arterial injury in hyperlipidemic mice involves early monocyte recruitment and CCL2 presentation on platelets
A Schober et al.
CIRCULATION RESEARCH (2004)
Chemokines in innate and adaptive host defense: Basic chemokinese grammar for immune cells
A Rot et al.
ANNUAL REVIEW OF IMMUNOLOGY (2004)
Transplantation of monocyte CC-chemokine receptor 2-deficient bone marrow into ApoE3-Leiden mice inhibits atherogenesis
J Guo et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2003)
Association between plasma levels of monocyte chemoattractant protein-1 and long-term clinical outcomes in patients with acute coronary syndromes
JA de Lemos et al.
CIRCULATION (2003)
Propagermanium reduces atherosclerosis in apolipoprotein E knockout mice via inhibition of macrophage infiltration
T Yamashita et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2002)
Local overexpression of monocyte chemoattractant protein-1 at vessel wall induces infiltration of macrophages and formation of atherosclerotic lesion - Synergism with hypercholesterolemia
M Namiki et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2002)
Share Paper
